RELX 📈 Relx ADR - Overview
Exchange: NYSE • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US7595301083
RELX: Analytics, Data, Information, Risk, Legal, Scientific, Medical
RELX PLC, a multinational company, operates a diverse portfolio of businesses that cater to the information needs of professionals and businesses worldwide. Through its four primary segments - Risk, Scientific, Technical & Medical, Legal, and Exhibitions - the company delivers a wide range of analytics and decision tools. The Risk segment, for instance, utilizes advanced technology and algorithms to provide clients with predictive insights, enabling them to assess and mitigate potential risks. By combining public and industry-specific content, this segment offers a comprehensive suite of solutions for risk evaluation and management.
The Scientific, Technical & Medical segment is another key area of focus for RELX PLC, where the company provides critical information and data sets to researchers and healthcare professionals. This enables them to advance scientific knowledge, improve health outcomes, and develop new treatments. The segment's offerings include access to vast repositories of scientific literature, clinical trial data, and other resources that facilitate evidence-based decision-making. By supporting the scientific community, RELX PLC plays a vital role in driving innovation and progress in the medical and scientific fields.
In the Legal segment, RELX PLC offers a broad range of legal, regulatory, and business information and analytics. These solutions are designed to support decision-making, enhance productivity, and streamline workflows for legal professionals. The company's legal information services include access to comprehensive databases of case law, legislation, and regulatory materials, as well as tools for legal research, document management, and practice management. By providing these resources, RELX PLC helps legal professionals navigate complex regulatory environments and stay up-to-date with the latest developments in the field.
The Exhibitions segment represents a unique aspect of RELX PLC's business, where the company combines face-to-face interactions with data and digital tools to facilitate learning, product sourcing, and transaction completion. This segment is involved in organizing trade shows, conferences, and other events that bring together professionals from various industries. By leveraging its expertise in data and analytics, RELX PLC creates engaging and informative experiences that help attendees connect with each other, discover new products and services, and drive business growth. With a history dating back to 1903, RELX PLC has evolved significantly over the years, adopting the name RELX PLC in 2015 and maintaining its headquarters in London, the United Kingdom.
As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol RELX, RELX PLC is committed to delivering long-term value to its shareholders. With a global presence and a diverse portfolio of businesses, the company is well-positioned to capitalize on emerging trends and opportunities in the information services market. Through its website, https://www.relx.com, investors and customers can access a wealth of information about the company, including its financial performance, products and services, and corporate governance practices. RELX PLC's common stock is traded under the ISIN code US7595301083 and is classified under the GICS Sub Industry category of Research & Consulting Services.
Additional Sources for RELX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RELX Stock Overview
Market Cap in USD | 87,331m |
Sector | Industrials |
Industry | Specialty Business Services |
GiC Sub-Industry | Research & Consulting Services |
IPO / Inception | 1994-10-07 |
RELX Stock Ratings
Growth 5y | 86.6% |
Fundamental | 76.4% |
Dividend | 46.0% |
Rel. Strength Industry | 9.84 |
Analysts | 4/5 |
Fair Price Momentum | 47.87 USD |
Fair Price DCF | 60.26 USD |
RELX Dividends
Dividend Yield 12m | 1.67% |
Yield on Cost 5y | 3.41% |
Annual Growth 5y | 4.25% |
Payout Consistency | 91.5% |
RELX Growth Ratios
Growth Correlation 3m | -28.3% |
Growth Correlation 12m | 89.6% |
Growth Correlation 5y | 92.6% |
CAGR 5y | 15.25% |
CAGR/Mean DD 5y | 2.25 |
Sharpe Ratio 12m | 0.79 |
Alpha | -7.48 |
Beta | 0.97 |
Volatility | 18.81% |
Current Volume | 4246k |
Average Volume 20d | 687k |
As of December 21, 2024, the stock is trading at USD 45.47 with a total of 4,245,992 shares traded.
Over the past week, the price has changed by -3.25%, over one month by +1.08%, over three months by -4.88% and over the past year by +19.68%.
Yes, based on ValueRay Fundamental Analyses, Relx ADR (NYSE:RELX) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 76.37 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RELX as of December 2024 is 47.87. This means that RELX is currently overvalued and has a potential downside of 5.28%.
Relx ADR has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy RELX.
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, RELX Relx ADR will be worth about 53 in December 2025. The stock is currently trading at 45.47. This means that the stock has a potential upside of +16.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 50.1 | 10.2% |
Analysts Target Price | 40.9 | -10% |
ValueRay Target Price | 53 | 16.5% |